Search

everythinglearnresearchcommunity

for

Search:↓

A certain genetic variation in the IL1A gene may lower the risk of a hair loss condition in Chinese people.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Dermatologists' treatment of alopecia areata is inconsistent, especially for children and advanced stages.

The health of the gut may be important in developing new ways to prevent, diagnose, and treat alopecia areata.

OCT can detect hidden hair follicles in alopecia areata, indicating potential hair regrowth.

A combination of methotrexate injections and CO2 laser treatment led to complete hair regrowth in two patients with hard-to-treat alopecia.

Low vitamin D might be one of several factors involved in the hair loss condition alopecia areata.

Azathioprine may help treat severe alopecia areata, but more research is needed.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

Most children with alopecia areata improved with treatment, but those with more hair loss had worse outcomes.

Cryotherapy may be an effective and simple treatment for mild hair loss with few side effects.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

Skin grafts on mice can cause an immune response leading to hair loss, useful for studying human hair loss conditions.

Alopecia areata significantly lowers the quality of life, especially in emotional and mental health aspects.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Alopecia areata treatment varies, with no optimal method established yet.

Minoxidil and finasteride are effective for male hair loss, minoxidil for female hair loss, and various treatments like corticosteroids work for alopecia areata; treatment should be tailored to the individual.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

Kids with alopecia areata may experience more stress but not necessarily feel more anxious or depressed than others.

Black dots under trichoscopy can appear in different hair and scalp conditions, not just in alopecia areata.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.